Home › Funds › First Eagle Investment Management › ELV

First Eagle Investment Management position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

First Eagle Investment Management reported holding 4,198,657 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$1.63B, representing 2.57% of its reported portfolio and ranking #8 among its reported holdings. First Eagle Investment Management has disclosed ELV holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)4.20M sh
Reported value held$1.63B
Portfolio Weight2.57%
First reportedQ3 2021
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How First Eagle Investment Management's ELV position evolved

First Eagle Investment Management first disclosed a stake in ELV in Q3 2021 at 2,046,440 shares (US$762.9M). The position peaked in Q3 2026 at 4,198,657 shares, worth US$1.63B. Across 21 filings, First Eagle Investment Management increased the stake 9 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 4,198,657 shares valued at US$1.63B. Notable position changes include a 48% increase in Q4 2024 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 2.05M $762.91M New
Q4 2021 2.02M $935.36M Reduce
Q1 2022 2.03M $996.68M Add
Q2 2022 2.01M $970.47M Reduce
Q3 2022 1.84M $835.77M Reduce
Q4 2022 1.79M $918.47M Reduce
Q1 2023 1.80M $825.64M Hold
Q2 2023 1.81M $802.01M Add
Q3 2023 1.78M $776.26M Reduce
Q4 2023 1.78M $838.66M Hold
Q1 2024 1.78M $924.34M Hold
Q2 2024 2.06M $1.12B Add
Q3 2024 2.19M $1.14B Add
Q4 2024 3.23M $1.19B Add
Q1 2025 3.24M $1.41B Hold
Q2 2025 3.20M $1.24B Reduce
Q3 2025 4.00M $1.29B Add
Q4 2025 4.02M $1.41B Add
Q1 2026 4.13M $1.21B Add
Q2 2026 4.19M $1.62B Add
Q3 2026 4.20M $1.63B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 22 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has First Eagle Investment Management held ELV?

First Eagle Investment Management has disclosed ELV holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is First Eagle Investment Management's current position in ELV?

As of Q3 2026, First Eagle Investment Management holds 4.20M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $1.63B, representing 2.57% of its reported portfolio and ranking #8.

Has First Eagle Investment Management been buying or selling ELV?

In the latest 13F filing (Q3 2026), First Eagle Investment Management held unchanged its position in ELV. The position peaked in Q3 2026 at 4.20M shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.